Audience: Health Professional June 26, 2024 -- Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor (CAR) T cell...
Vous n'êtes pas connecté
Charles River (CRL) signs a lentiviral vector contract development and manufacturing organization agreement with Gates Institute to help develop chimeric antigen receptor (CAR) T-cell therapies.
Audience: Health Professional June 26, 2024 -- Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor (CAR) T cell...
Quest Diagnostics (DGX) signs an agreement to acquire Allina Health's select laboratory assets. The deal is aimed at expanding Quest Diagnostics'...
Charles River (CRL) broadens the scope of its products and services across the drug discovery and early-stage development continuum through focused...
Amara Raja holding a 35% market share of India's battery manufacturing, signs lithium-ion battery technology pact.
Petroliam Nasional Bhd (PETRONAS) has inked a small field asset production-sharing contract (PSC) with Vestigo Petroleum Sdn Bhd for a discovered...
State Street (STT) enters into a partnership agreement with Galaxy Digital to enhance its digital-based offerings. This move aligns with the company's...
Competitive: Barrington James: Company Profile: We are a full-service contract research organisation (CRO) and Contract Development Manufacturing...
EDINBURGH, Scotland & BOSTON — RoslinCT, a leading cell and gene therapy Contract Development and Manufacturing Organisation (CDMO), is...
ISKANDAR PUTERI: Iskandar Investment Bhd (IIB), the master developer of Iskandar Puteri, via River Retreat Sdn Bhd, has entered into a strategic...